Oral PD-L1 inhibitor GS-4224 selectively engages PD-L1 high cells and elicits pharmacodynamic responses in patients with advanced solid tumors
==============================================================================================================================================

* Jared M Odegard
* Ahmed A Othman
* Kai-Wen Lin
* Adele Y Wang
* Jonathan Nazareno
* Oh Kyu Yoon
* John Ling
* Latesh Lad
* P Rod Dunbar
* Dung Thai
* Edmond Ang
* Nicholas Waldron
* Sanjeev Deva